Mahmudul Haq, MD
Gastroenterology · Oxford, FLNPI 1619911146
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 64 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by AbbVie at 40.4% of the total. Reporting peaked in 2019 at $1,239 and has fallen 84.8% since, to $188 in 2023. That places this record below the midpoint for gastroenterology clinicians in FL, where the typical reported total is $3,025.
Across 64 payments — averaging $23.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$604
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$197
- Fujifilm Healthcare Americas Corporation$188
- Gilead$183
- Ironwood Pharmaceuticals, Inc$86
- Neuronetics, Inc.$68
- plus $168 from 7 others
Across 6 payments — averaging $32.84 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boehringer Ingelheim International GmbH$197
What the payments were for
- Food & beverage$1,494100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 28 | $604 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 12 | $197 |
| Fujifilm Healthcare Americas Corporation | 1 | $188 |
| Gilead | 9 | $183 |
| Ironwood Pharmaceuticals, Inc | 5 | $86 |
| Neuronetics, Inc. | 1 | $68 |
| Scilex Pharmaceuticals Inc. | 1 | $65 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $29 |
| Vapotherm Inc | 1 | $22 |
| Emergent Biosolutions Inc. | 1 | $20 |
| Nestle Healthcare Nutrition Inc. | 1 | $16 |
| Daiichi Sankyo Inc. | 1 | $13 |
| Romark Laboratories, LC | 1 | $2 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FUJIFILM$188
How this compares
$1,494 in reported general payments places this provider in the 30th percentile of 1,388 gastroenterology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gastroenterology in Oxford
- Samuel GidayOrlando$2M
- Lukasz KwapiszMiami$1.2M
- Jennifer Seminerio-DiehlOrlando$1.1M
- Udayakumar NavaneethanSaint Petersburg$1.1M
- Ronen AraiCoral Springs$1.1M
- Charles SninskyGainesville$983K
- Peter DraganovGainesville$832K
- Arin NewmanMiami Beach$716K
- Joanna LopezMiami$670K
- Jose NietoSebring$573K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.